NSIM
ROIV icon

North Star Investment Management’s Roivant Sciences ROIV Stock Holding History

North Star Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354 Sell
10
-28
-74% -$827 ﹤0.01% 1702
2026
Q1 		$1.05K Buy
+38
New +$976 ﹤0.01% 1480

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

North Star Investment Management's ROIV Position: Q2 2026 in Review

North Star Investment Management reduced its Roivant Sciences (ROIV) stake by 74% in Q2 2026, selling an estimated $827 and leaving 10 shares worth $354. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

North Star Investment Management first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.05K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • North Star Investment Management held 10 shares of Roivant Sciences worth $354 as of Q2 2026.
  • North Star Investment Management sold 28 Roivant Sciences shares in Q2 2026, an estimated $827.
  • Roivant Sciences made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1702 holding.
  • North Star Investment Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • North Star Investment Management's Roivant Sciences position peaked at $1.05K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.